Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana

Rilpivirine (RPV) and Etravirine (ETR) are approved second-generation non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV treatment. There is a cross-resistance HIV mutation profile between first- and second-generation NNRTI drugs. We determined the prevalence of HIV-1 drug resistance m...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:AIDS Res Hum Retroviruses
Autori principali: Diphoko, Thabo, Gaseitsiwe, Simani, Kasvosve, Ishmael, Moyo, Sikhulile, Okatch, Harriet, Musonda, Rosemary, Wainberg, Mark, Makhema, Joseph, Marlink, Richard, Novitsky, Vladimir, Essex, Max
Natura: Artigo
Lingua:Inglês
Pubblicazione: Mary Ann Liebert, Inc. 2018
Soggetti:
Epidemiology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6079649/
https://ncbi.nlm.nih.gov/pubmed/29732907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2017.0135
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi